Scientists uncover how ovarian cancer resists chemotherapy-and how to reverse it

Michigan State University researchers have discovered that the protein TPPP3 helps ovarian cancer cells resist chemotherapy by stabilizing their internal scaffolding. Blocking this protein could potentially restore the effectiveness of standard treatments like cisplatin.
Why it matters
This finding offers a promising new therapeutic target to overcome drug resistance in ovarian cancer patients, potentially improving survival rates.
by Dalin Clark, Michigan State University
Scientific reporting based on peer-reviewed research findings.
Get smarter about the news
Sign up free for a feed built around what you actually care about, Dive Deeper research on any story, and the full text of every article.
Create free accountAlready have an account? Sign in